OppenheimerFunds Inc. purchased a new stake in shares of Healthways, Inc. (NASDAQ:TVTY) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 14,136 shares of the company’s stock, valued at approximately $412,000.
Several other institutional investors also recently made changes to their positions in the stock. Wells Fargo & Company MN acquired a new stake in Healthways during the first quarter valued at approximately $98,404,000. JPMorgan Chase & Co. bought a new position in shares of Healthways during the first quarter worth $34,618,000. Hood River Capital Management LLC bought a new position in shares of Healthways during the first quarter worth $29,974,000. American Capital Management Inc. increased its position in shares of Healthways by 0.6% in the first quarter. American Capital Management Inc. now owns 900,800 shares of the company’s stock worth $26,213,000 after buying an additional 5,075 shares during the period. Finally, Eagle Asset Management Inc. bought a new position in shares of Healthways during the first quarter worth $22,592,000.
Healthways, Inc. (TVTY) opened at 40.80 on Friday. The stock’s market cap is $1.60 billion. Healthways, Inc. has a 52-week low of $16.04 and a 52-week high of $41.55. The firm’s 50-day moving average is $39.17 and its 200-day moving average is $31.53.
Healthways (NASDAQ:TVTY) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. The business had revenue of $138.90 million for the quarter, compared to analyst estimates of $138.15 million. Healthways had a return on equity of 31.60% and a net margin of 17.30%. Healthways’s quarterly revenue was up 11.1% compared to the same quarter last year. Equities research analysts predict that Healthways, Inc. will post $1.55 earnings per share for the current year.
A number of analysts have commented on TVTY shares. ValuEngine raised shares of Healthways from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Zacks Investment Research raised shares of Healthways from a “hold” rating to a “buy” rating and set a $32.00 target price for the company in a research note on Wednesday, April 26th. Jefferies Group LLC reaffirmed a “buy” rating and set a $36.00 target price (up from $33.00) on shares of Healthways in a research note on Saturday, April 29th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $41.00 price objective (up previously from $32.00) on shares of Healthways in a research report on Monday, May 1st. Finally, UBS AG raised their target price on shares of Healthways from $37.00 to $43.00 and gave the stock a “buy” rating in a report on Friday, June 23rd. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $35.25.
In related news, Director Mary Jane England sold 1,763 shares of the business’s stock in a transaction that occurred on Wednesday, May 3rd. The stock was sold at an average price of $31.95, for a total transaction of $56,327.85. Following the transaction, the director now directly owns 19,453 shares of the company’s stock, valued at approximately $621,523.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 8.42% of the company’s stock.
About Healthways
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
